Latest News and Press Releases

Ken Paxton’s Lululemon investigation (NASDAQ:LULU) is a wake-up call for the entire synthetic textile industry, as it’s time to move to better fibers like

Annual General Meeting of Kuros Biosciences approves all resolutions Schlieren (Zurich), Switzerland, April 15, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone...

BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...

BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) -- Poster presentations to feature data from clinical asset BV100 addressing carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex...

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Annotation Services for Roadway AI Models Market Report 2026" has been added to ResearchAndMarkets.com's offering. The annotation services for...

Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026 Financial Highlights Total...

CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (TSX: BNE) (“Bonterra” or the “Company”) is pleased to announce that the Toronto Stock Exchange (“TSX”) has accepted the...

FRISCO, Texas and PASADENA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- In a move that signals a structural shift in how commodities are accessed and monetized, Novarra BBX, LLC and Happy Gold, LLC...

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet need,...

Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T...